Literature DB >> 27475468

Medication adherence in Alzheimer's disease: The mediator role of mindfulness.

Sara Lima1, Miguel Gago2, Carolina Garrett3, M Graça Pereira4.   

Abstract

BACKGROUND: Medication adherence is often assessed based on compliance to the dosage and frequency of physician's prescription. Cognitive impairment is one of the biggest barriers in elderly patients with Alzheimer's disease (AD), who are usually polymedicated with different oral drugs. Transdermal drug delivery, also requires mobility abilities, reinforcing the role of patients' caregivers.
OBJECTIVE: To evaluate the relationship between psychological variables such as social support, family satisfaction, psychological morbidity, awareness of the disease, coping, mindfulness and medication adherence, in patients with AD, taking in consideration the patient's perspective.
DESIGN: Cross-sectional and quantitative study including 128 patients with mild AD.
RESULTS: Medication adherence showed a positive relationship with social support, mindfulness, family satisfaction and awareness of the disease. Mindfulness was a mediator in the relationship between awareness of the disease and medication adherence.
CONCLUSIONS: This study reinforces the importance of psychological assessment in medication adherence in mild AD patients, specially the role of mindfulness. Intervention programs to promote mindfulness may have a potential dual benefit, preserving cognitive skills and promoting medication adherence.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Adherence; Alzheimer’s patients; Mindfulness

Mesh:

Year:  2016        PMID: 27475468     DOI: 10.1016/j.archger.2016.06.021

Source DB:  PubMed          Journal:  Arch Gerontol Geriatr        ISSN: 0167-4943            Impact factor:   3.250


  7 in total

Review 1.  A geroscience motivated approach to treat Alzheimer's disease: Senolytics move to clinical trials.

Authors:  Mitzi M Gonzales; Sudarshan Krishnamurthy; Valentina Garbarino; Ali S Daeihagh; Gregory J Gillispie; Gagan Deep; Suzanne Craft; Miranda E Orr
Journal:  Mech Ageing Dev       Date:  2021-10-21       Impact factor: 5.498

2.  Pharmacokinetics and Bioequivalence of Memantine Tablet and a New Dry Syrup Formulation in Healthy Japanese Males: Two Single-Dose Crossover Studies.

Authors:  Yutaro Maekawa; Setsuo Hasegawa; Tomoko Ishizuka; Kazuhito Shiosakai; Hitoshi Ishizuka
Journal:  Adv Ther       Date:  2019-08-09       Impact factor: 3.845

3.  Selected psychological predictors of medication adherence in the older adults with chronic diseases.

Authors:  Magdalena Gruszczyńska; Julia Wyszomirska; Anna Daniel-Sielańczyk; Monika Bąk-Sosnowska
Journal:  Nurs Open       Date:  2020-10-23

4.  A phenomenological study on barriers of adherence to medical advice among type 2 diabetic patients.

Authors:  Monire Davoodi; Behnaz Dindamal; Hossein Dargahi; Farzad Faraji-Khiavi
Journal:  BMC Endocr Disord       Date:  2022-01-06       Impact factor: 2.763

5.  Differences in treatment for Alzheimer's disease between urban and rural areas in China.

Authors:  Bei Li; Dejun Liu; Qiaoqin Wan; Can Sheng; Xiting Wang; Fangda Leng; Qing Peng; Ting Wang; Ailian Du; Feiqi Zhu; Dunzhu Mima; Huali Wang; Hengge Xie; Zhaoxia Wang; Haiqiang Jin; Yongan Sun
Journal:  Front Neurol       Date:  2022-09-29       Impact factor: 4.086

6.  Medication Adherence and Coping with Disease in Patients from a Neurological Clinic: An Observational Study.

Authors:  Gabriele Helga Franke; Julia Nentzl; Melanie Jagla-Franke; Tino Prell
Journal:  Patient Prefer Adherence       Date:  2021-06-28       Impact factor: 2.711

7.  The Influence of Selected Psychological Factors on Medication Adherence in Patients with Chronic Diseases.

Authors:  Monika Bąk-Sosnowska; Magdalena Gruszczyńska; Julia Wyszomirska; Anna Daniel-Sielańczyk
Journal:  Healthcare (Basel)       Date:  2022-02-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.